Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

Apple stock rises after falling Thursday by 4%, the most since August, Qorvo stock jumps following a report that activist ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...

Accounting for around one-quarter of Europe's market cap, the GRANOLAS members are: GSK (GSK) (UK:GSK), Roche (CH:ROG), ASML (ASML) (NL:ASML), Nestlé (CH:NESN) (NSRGY), Novartis (NVS) (CH:NOVN), Novo ...

Drugmakers will have until the end of February to decide whether they want to participate in the second round of Medicare ...

Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...

The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration.

At the moment, the hottest GLP-1 treatment is Ozempic. Danish pharmaceutical leader Novo Nordisk (NYSE: NVO) is the brains behind Ozempic, as well as sibling GLP-1 medications including Wegovy ...

“According to the writer, obesity seems to be a matter of lack—a lack of bariatric surgeries and a lack of Ozempic courtesy of Novo Nordisk, a Danish multinational whose wealth is bigger ...